Marinus Pharmaceuticals, Inc, a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, announced that the Committee for Medicinal Products...
Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, announced that Nuvaxovid™ (NVX-CoV2373) COVID-19 vaccine has been...
Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, announced that the Nuvaxovid™ (NVX-CoV2373) COVID-19 vaccine has...
